Why didn’t nonprofits and the NIH require ‘reasonable’ pricing for Zolgensma? That may happen in France
(By James Love for STAT) When a new drug emerges from research largely funded by grants from charities and government
Read More(By James Love for STAT) When a new drug emerges from research largely funded by grants from charities and government
Read More(By Jackie Drees for Becker’s Hospital Review) The Veterans Health Administration 2016 telehealth initiative to distribute video-enabled tablets to veterans with mental
Read More(By Maia Anderson for Becker’s Hospital Review) Although rebates for brand-name drugs in Medicare Part D substantially reduced drug spending,
Read More(By Jon Hamilton for NPR) Researchers are beginning to understand why certain brain cancers are so hard to stop. Three
Read More(By Emily Vaughn for NPR) An outbreak of severe lung disease among users of electronic cigarettes continues to spread to
Read MoreIn Doug Badger, senior fellow at the Galen Institute, opinion column published by The Daily Signal, writes how according to
Read More(By Kelly Gooch for Becker’s Hospital Review) Leaders on the House and Senate Veterans Affairs Committees are calling on the
Read More(By Megan Thielking for STAT) Barbara Metcalf and Mary Smallwood live 826 miles apart. They’ve never met in person. If
Read More(By Anna Almendrala and Ana B. Ibarra for Kaiser Health News) SACRAMENTO, Calif. — Demographers, gerontologists and government officials are
Read More(By Morgan Haefner for Becker’s Hospital Review) Here are five updates on issues surrounding “Medicare for All” proposals published by Becker’s
Read More